Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > crpof is on the right track
View:
Post by Finallytherock on Aug 25, 2020 9:38pm

crpof is on the right track

they seem to have "righted" the ship. earnings were fantastic. i expect it to continue. so much going on here. great news can break at any point
Comment by Ciao on Aug 27, 2020 11:34am
Are you based in the US? How did you hear about Ceapro?
Comment by Finallytherock on Aug 27, 2020 12:04pm
i am in the US. i actually owned shares years ago (maybe around 2016). i made a decent profit when it ran up but thought that things were moving too slowly so i sold, once in a while i would check out the stock and would see it sink lower and lower. i always thought it had great potential but when the stock was near an all time low, i figured maybe i was wrong. finally they announced great numbers ...more  
Comment by Ciao on Aug 27, 2020 12:42pm
Everything is relative, you're back in at a good time. The Noble analyst had 2020 year rev at $13.4M, R&D at $2.7M and net income at -2.2M. After H1, rev. is at $8.9M, R&D at .9M and net income at $2.2M. If H2 is similar to H1, and even with R&D picking up to say $1.5M in H2, we could hit $3 - $3.8M, or conservatively .04 EPS. This year we are given an opportunity to use ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities